Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Chk1 Binds and Phosphorylates BAD Protein

EDWARD KYU-HO HAN, CHRIS BUTLER, HAICHAO ZHANG, JEAN M. SEVERIN, WENYING QIN, TOM F. HOLZMAN, EARL J. GUBBINS, ROBERT L. SIMMER, SAUL ROSENBERG, VINCENT L. GIRANDA, SHI-CHUNG NG and Y. LUO
Anticancer Research November 2004, 24 (6) 3907-3910;
EDWARD KYU-HO HAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHRIS BUTLER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HAICHAO ZHANG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JEAN M. SEVERIN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WENYING QIN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOM F. HOLZMAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EARL J. GUBBINS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ROBERT L. SIMMER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SAUL ROSENBERG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
VINCENT L. GIRANDA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHI-CHUNG NG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y. LUO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Chk1 (checkpoint kinase 1) is a serine-threonine kinase that is critical for G2/M arrest in response to DNA damage. Chk1 phosphorylates Cdc25C at serine-216, a major regulatory site, in response to DNA damage. Furthermore, Chk1 also phosphorylates Cdc25A on serine 123 which accelerates its degradation through the ubiquitin-proteasome pathway and arrests cells in late G2-phase after DNA damage. In the present study, we demonstrated that Chk1 phosphorylates pro-apoptotic protein BAD (Bcl-2/Bcl-XL-Antagonist, causing cell Death) in vitro. In vitro phosphorylation analysis with various mouse BAD peptides has revealed two phosphorylation sites for Chk1 at serine-155 and serine-170. When wild-type and mutant BAD (S155A) constructs were transfected into 293T cells, an association between BAD and Chk1 was observed by co-immunoprecipitation. In addition, there was an increase in the phosphorylation of serine-155 following DNA damage by adriamycin treatment. Our results suggest that Chk1 associates with BAD and phosphorylates the BAD protein at serine-155. Taken together, our results suggest that Chk1 may inactivate BAD by associating with and phosphorylating residues critical for BAD function in response to DNA damage.

Footnotes

  • Received July 28, 2004.
  • Accepted October 18, 2004.
  • Copyright© 2004 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research: 24 (6)
Anticancer Research
Vol. 24, Issue 6
Novemeber-December 2004
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Chk1 Binds and Phosphorylates BAD Protein
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 5 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Chk1 Binds and Phosphorylates BAD Protein
EDWARD KYU-HO HAN, CHRIS BUTLER, HAICHAO ZHANG, JEAN M. SEVERIN, WENYING QIN, TOM F. HOLZMAN, EARL J. GUBBINS, ROBERT L. SIMMER, SAUL ROSENBERG, VINCENT L. GIRANDA, SHI-CHUNG NG, Y. LUO
Anticancer Research Nov 2004, 24 (6) 3907-3910;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Chk1 Binds and Phosphorylates BAD Protein
EDWARD KYU-HO HAN, CHRIS BUTLER, HAICHAO ZHANG, JEAN M. SEVERIN, WENYING QIN, TOM F. HOLZMAN, EARL J. GUBBINS, ROBERT L. SIMMER, SAUL ROSENBERG, VINCENT L. GIRANDA, SHI-CHUNG NG, Y. LUO
Anticancer Research Nov 2004, 24 (6) 3907-3910;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • CaMKII-{gamma} mediates phosphorylation of BAD at Ser170 to regulate cytokine-dependent survival and proliferation
  • Google Scholar

More in this TOC Section

  • The Prognostic Significance of p16 and its Role as a Surrogate Marker for Human Papilloma Virus in Oral Squamous Cell Carcinoma: An Analysis of 281 Cases
  • Diagnostic Value of Circulating Cell-free DNA in Patients With Papillary Thyroid Cancer
  • Changes in Lysophospholipid Components in Ulcerative Colitis and Colitis-associated Cancer
Show more Experimental Studies

Similar Articles

Anticancer Research

© 2022 Anticancer Research

Powered by HighWire